HHS-NIH-NIAID-BAA2020-1 Research Area 004: Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections, and Emerging Infectious Diseases Supports development of promising new therapeutics to address infections caused by NIAID Category
HHS-NIH-NIAID-BAA2020-1 Research Area 003: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Supports development of vaccines 1) to address antibiotic resistant gram-negative bacteria focusing on but not
HHS-NIH-NIAID-BAA2020-1 Research Area 005: Advanced Development of Diagnostics for Biothreats and Emerging Infectious Diseases Supports advancing the development of novel, rapid sample-to-answer candidate diagnostic products that will address biodefense and
Join Trust for America's Health (TFAH) on Wednesday, April 15th for the webinar Protecting Against the Harms of Social Isolation During COVID-19. The ongoing COVID-19 crisis presents unique challenges for
Brought to you by the American Public Health Association and the National Academy of Medicine, this webinar series is exploring the state of the science surrounding the current outbreak of
The FDA and the University of Texas Medical Branch, Galveston National Laboratory (UTMB) will host this year's annual training course on how to meet GLP requirements in BSL-4 facilities from April
Join the Defence and Security Accelerator for a dial-in on 21 April 2020, 1pm to 2pm. The competition team will provide a short briefing on the Biosensing Across Wide Areas
Innovators within the fields of pediatric oncology, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150,000 in grant funding; one year of
"After careful consideration, ASM’s Clinical Virology Symposium will not be held May 3-6, 2020. Based on the U.S. Centers for Disease Control and Prevention’s recent recommendation against holding gatherings with
